Literature DB >> 1951543

Transforming growth factor-beta 1 expression during placental development.

L J Dungy1, T A Siddiqi, S Khan.   

Abstract

Placental growth has several malignant characteristics, including properties of invasiveness, rapid cell proliferation, and a lack of cell contact inhibition. These malignant characteristics of placental development are strictly regulated throughout normal gestation, because placental growth is limited in both extent and duration. Transforming growth factor-beta 1 inhibits growth of many normal and malignant cell lines. In this study, using Northern blot analysis, we found transforming growth factor-beta 1 expression to occur in human placenta throughout gestation. Peak expression was noted at midgestation (near 17 weeks) and again in late gestation (near 34 weeks). Immunohistochemical analysis localized transforming growth factor-beta 1 protein expression to the syncytiotrophoblastic layer. The process of trophoblastic invasion of the decidua and myometrium is usually complete by 18 weeks of gestation, and absolute growth of the placenta ceases in late gestation (near 35 weeks). The time frames of maximal transforming growth factor-beta 1 expression noted in our studies correlate with these events. We speculate that peak transforming growth factor-beta 1 expression at these stages of placental development is suggestive of its regulation of both trophoblastic invasion and proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951543     DOI: 10.1016/0002-9378(91)90428-t

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  Regulation of growth and function of the human placenta.

Authors:  S Rama; A Jagannadha Rao
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage.

Authors:  M S Ogasawara; K Aoki; T Aoyama; K Katano; Y Iinuma; Y Ozaki; K Suzumori
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction.

Authors:  F Lyall; H Simpson; J N Bulmer; A Barber; S C Robson
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Expression of TGF-betal in placenta of the patients with pregnancy-induced hypertension and its relationship with serum VCAM-1.

Authors:  Wenpei Xiang; Xiaoyan Xu; Hanping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Upregulation of cytokines is detected in the placentas of cattle infected with Neospora caninum and is more marked early in gestation when fetal death is observed.

Authors:  Anne Rosbottom; E Helen Gibney; Catherine S Guy; Anja Kipar; Robert F Smith; Pete Kaiser; Alexander J Trees; Diana J L Williams
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

Review 6.  Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.

Authors:  Corinne Rusterholz; Sinuhe Hahn; Wolfgang Holzgreve
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

7.  Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha.

Authors:  P M Drake; M D Gunn; I F Charo; C L Tsou; Y Zhou; L Huang; S J Fisher
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

8.  Decidualization and syndecan-1 knock down sensitize endometrial stromal cells to apoptosis induced by embryonic stimuli.

Authors:  Sarah Jean Boeddeker; Dunja Maria Baston-Buest; Tanja Fehm; Jan Kruessel; Alexandra Hess
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

9.  The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation.

Authors:  Karen Forbes; Laura Skinner; John D Aplin; Melissa Westwood
Journal:  Cell Mol Life Sci       Date:  2012-07-15       Impact factor: 9.261

Review 10.  Shifting perspectives from "oncogenic" to oncofetal proteins; how these factors drive placental development.

Authors:  Rachel C West; Gerrit J Bouma; Quinton A Winger
Journal:  Reprod Biol Endocrinol       Date:  2018-10-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.